osimertinib,tepotinib
astrazeneca,merck
['thank you', 'osimertinib', 'nsclc', 'sclc', 'tepotinib']
thank you , , for stopping by to speak with us at onclive! dr. mazieres highlighted tepotinib + osimertinib for egfrm nsclc w/ metamp after progression on first-line (1l) osimertinib. check back to our site for more on the topic! #esmo22 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.